Herve Hoppenot

Herve Hoppenot

Chief Executive Officer at INCYTE CORPORATION

Net worth: 29 M $ as of 30/03/2024

64 year
Health Technology
Commercial Services
Process Industries

Profile

Herve Hoppenot holds the position of Chairman, President & Chief Executive Officer of Incyte Corp. He is also on the board of Biotechnology Innovation Organization, Cellectis SA and Pharmaceutical Research & Manufacturers of America. In his past career he was President at Novartis Oncology, Inc., President for Novartis Pharmaceuticals Corp., Head-US Oncology Business Unit at Aventis SA, Vice President-Oncology Division at Aventis Pharmaceuticals, Inc., Principal at Rhone Poulenc AG, Inc. and Head-US Oncology Business Unit at Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/02/2024 502,333 ( 0.22% ) 29 M $ 30/03/2024
13/02/2023 0 ( -.--% ) - $ 30/03/2024

Herve Hoppenot active positions

CompaniesPositionStart
INCYTE CORPORATION Chief Executive Officer 12/01/2014
Director/Board Member -
Director/Board Member -
Director/Board Member 31/10/2021
All active positions of Herve Hoppenot

Former positions of Herve Hoppenot

CompaniesPositionEnd
CELLECTIS S.A. Director/Board Member 26/06/2023
President 31/12/2013
President 31/12/2013
Corporate Officer/Principal 31/12/2002
Rhone-Poulenc Rorer Pharmaceuticals, Inc. Corporate Officer/Principal 31/12/1999
See the detail of Herve Hoppenot's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Herve Hoppenot's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INCYTE CORPORATION

Health Technology

CELLECTIS S.A.

Health Technology

Private companies9

Health Technology

Health Technology

Commercial Services

Health Technology

Rhone Poulenc AG, Inc.

Process Industries

Health Technology

Health Technology

Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Herve Hoppenot